Workflow
Biometric Technology and Identity Access Management
icon
Search documents
BIO-key Reports 2025 Results and Substantially Improved Cash Position, Supporting Expected Strong Growth in 2026; Investor Call Today at 10am ET
Globenewswire· 2026-03-31 12:30
Core Insights - BIO-key International, Inc. reported solid revenue growth and improved bottom line for 2026, with preliminary Q1'26 revenue expected to be $2.2 million, representing a 37% increase compared to Q1'25 and an 80% increase compared to Q4'25 [2][3] - The company completed a strategic transition to selling only BIO-key branded solutions in the EMEA region, which is expected to enhance gross margins and growth prospects despite a decrease in license revenue in 2025 [2][3] Financial Performance - 2025 total revenue decreased by approximately 12% to $6.1 million from $6.9 million in 2024, primarily due to a significant contract renewal with a foreign retail bank in 2024 and the exit from the Swivel Secure distribution agreement [13] - License fee revenue decreased by $1.6 million, or 31%, while hardware revenue increased over 100% to $1.3 million, driven by increased purchases of biometric hardware solutions [13] - Gross profit declined to $4.7 million with a gross margin of 77.5% in 2025, compared to $5.6 million and 81.4% in 2024, reflecting lower license fees and increased hardware revenues [14] Customer and Market Expansion - The company is experiencing strong demand from foreign government, defense, and financial customers, benefiting from supportive regulatory frameworks and global tensions [4] - BIO-key launched a Defense & Intelligence Cybersecurity Initiative in 2025 to capitalize on increased global defense spending, particularly in Europe and the Middle East [5] - Significant new partnerships have been established in India, Vietnam, the Middle East, and the Nordic region, enhancing the company's geographic reach [7][15] Cost Management and Financial Strength - Operating expenses were reduced by $768,000, or 11%, in 2025, contributing to a stronger financial position with $2.7 million in cash at year-end [11] - The company's book value increased to $7.6 million at the end of 2025, up from $3.8 million at the end of 2024 [17] Strategic Initiatives - A $1 million annual license renewal was secured with a foreign retail bank for the expanded use of BIO-key's biometric identity solution, serving over 30 million clients [8] - The partnership with TD Synnex Public Sector aims to deliver security solutions to U.S. government agencies, addressing the need for Zero Trust infrastructure [9][10]
BIO-key Q2’25 Revenue Rose 49% Driven by Increases Across All Three Segments; Launches “BIO-key CyberDefense Initiative” to Support Growing Global Investment in Military and Defense Preparedness; Investor Call 10am ET Today
Globenewswire· 2025-08-13 12:30
Core Insights - BIO-key International, Inc. reported a 49% increase in Q2'25 revenues to $1.7 million compared to $1.1 million in Q2'24, driven by higher sales across its business segments [9][10] - The company is focusing on expanding its Identity and Access Management (IAM) solutions in the global defense market through the BIO-key CyberDefense Initiative, capitalizing on increased European defense spending [4][5] - The gross margin for Q2'25 was 73%, down from 77% in Q2'24, attributed to a rise in hardware sales, which typically have lower margins [7][11] Financial Performance - Q2'25 software license fees increased by 4% to $806,087, while services revenues rose to $321,996, and hardware sales surged to $568,824 from $83,492 in Q2'24 [9][10] - Total operating expenses decreased by 8.5% to $2.3 million, with a 13.5% reduction in selling, general, and administrative expenses [12] - The net loss for Q2'25 improved to $1.2 million, or $0.20 per share, compared to a net loss of $1.7 million, or $1.00 per share, in Q2'24 [13] Market Strategy - The company is refocusing its sales efforts on BIO-key branded solutions in EMEA and domestic markets, enhancing its market presence [3] - The BIO-key CyberDefense Initiative aims to establish partnerships with defense industry prime contractors, leveraging the growing demand for cybersecurity solutions [4][5] - BIO-key anticipates significant contract activity in the first half of next year, supported by a robust pipeline of opportunities [6] Balance Sheet and Cash Flow - As of June 30, 2025, total current assets were $4.0 million, including $2.3 million in cash and cash equivalents, compared to $1.9 million at the end of 2024 [14][22] - The company reduced its note payable by $0.4 million in Q2'25, leaving a balance of $0.3 million [14] - The net cash provided from financing activities in the first half of 2025 was $3.5 million, contributing to an increase in cash and cash equivalents to $2.3 million [26]